| Literature DB >> 34961560 |
Leiming Wu1,2,3,4, Mingliang Zhang1, Ran Zhang1,3, Haizhong Yu3, Hailang Wang1,3, Jingyang Li1,5, Youmei Wang1,3, Zhen Hu1,3, Yanting Wang1,3, Zi Luo2, Lin Li2, Lingqiang Wang1,6, Liangcai Peng1,3, Tao Xia7,8.
Abstract
BACKGROUND: As a major component of plant cell walls, cellulose provides the most abundant biomass resource convertible for biofuels. Since cellulose crystallinity and polymerization have been characterized as two major features accounting for lignocellulose recalcitrance against biomass enzymatic saccharification, genetic engineering of cellulose biosynthesis is increasingly considered as a promising solution in bioenergy crops. Although several transcription factors have been identified to regulate cellulose biosynthesis and plant cell wall formation, much remains unknown about its potential roles for genetic improvement of lignocellulose recalcitrance.Entities:
Keywords: Biomass saccharification; Cellulose polymerization; Cellulose synthesis; Fragile culm; Microfibril assembly; Multi-omics; OsMYBs; Rice
Year: 2021 PMID: 34961560 PMCID: PMC8713402 DOI: 10.1186/s13068-021-02093-8
Source DB: PubMed Journal: Biotechnol Biofuels ISSN: 1754-6834 Impact factor: 6.040
Fig. 1A map-based approach for cloning the myb103/Osfc9 gene. A The Osfc9 gene mapped to the region between markers SSR2 and RM4955 in a 46-kb region on the chromosome 8. The candidate gene of LOC_Os08g05520 identified with a single-base mutation in the end of the second intron for the 18-bp deletion in CDS sequence. B Six amino acid deletion in the R3 binding domain of the mutant
Fig. 2Phenotype observation of myb103 mutant and OsMYB103L-RNAi transgenic lines. A Images of WT (NPB, wild type), myb103 (Osfc9 mutant) and its complementary line. B Stem brittleness of WT, myb103 and its complementary line. C Gene expression analysis of OsMYB103L between WT and myb103. D Images of WT and two OsMYB103L-RNAi-transgenic lines (RNAi-1and RNAi-2). E Stem brittleness of WT and two OsMYB103L RNAi transgenic lines (RNAi-1 and RNAi-2). F Gene expression analysis of OsMYB103L in WT, and two OsMYB103L RNAi transgenic lines (RNAi-1 and RNAi-2). **As significant differences of two OsMYB103L-RNAi transgenic plants compared with WT at p < 0.01 (n = 3) with decreased ( −) percentage, respectively
Fig. 3Morphological observation of vascular bundles in stem tissues of myb103 mutant and RNAi transgenic line. A Examination of GUS activity by expressing proOsMYB103L:GUS. B View of vascular bundles development and distribution; the stem slices obtained with 100 μm thickness, and imaged using a Nikon Eclipse Ni-U microscope under bright field. C S4B cellulose staining; the stem slices obtained with 100 μm thickness, stained with S4B (Direct Red 23, Sigma), and imaged using a Nikon Eclipse Ni-U microscope under 530–560 nm excitation and 620–660 nm emission
Fig. 4Measurements of cell wall thickness and cell wall composition in myb103 mutant and RNAi transgenic line. A Observation of cell wall thickness by transmission electron microscopy. B Cell wall composition analysis. **As significant differences between myb103 and RNAi-1 with WT at p < 0.01 (n = 3). SCW, secondary cell wall. PCW primary cell wall
Fig. 5Characterization of cellulose features and microfibril assembly in myb103 mutant and RNAi line. A Cellulose CrI. B Cellulose DP. C Cellulose nano-microfibrils observed under atomic force microscopy. * and **as significant differences between myb103 and RNAi-1 with WT at p < 0.05 and 0.01 (n = 3) with decreased ( −) percentage, respectively
Fig. 6Biomass enzymatic saccharification of myb103 mutant and RNAi line under different pretreatments. A Hexoses yields released from direct enzymatic hydrolysis of raw material (without pretreatment). B Hexoses yields released after 1% H2SO4 pretreatment. C Hexoses yields released after 1% NaOH pretreatment. D Hexoses yields released under lipid hot water pretreatment (LHW) (30 min). **As significant differences between myb103 and RNAi-1 with WT at p < 0.01, (n = 3)
Fig. 7Biochemical identification of OsMYB103L binding sites. A Protein expression of HALO-tagged OsMYB103L and OsFC9 in vitro. B Peak analysis of OsMYB103L and OsFC9 by DAP-seq. C Protein structure prediction between OsMYB103L and OsFC9. D Distribution of combined peaks of OsMYB103L by DAP-seq. E Motif analysis of combined peaks of OsMYB103L with the most significant E-value. F Gene expression analysis of OsCESA4, OsCESA7 and OsCESA9 in WT, myb103 and RNAi-1. * and **as significant differences between myb103 and RNAi-1 with WT at p < 0.05 and 0.01 (n = 3), respectively
Fig. 8Multi-omics analysis of OsMYB103L regulation on cellulose synthesis and assembly. A Volcano analysis of significantly expressed genes of myb103 compared with WT by RNA-seq. B The number of genes overlapped by significantly expressed genes in myb103 mutant and OsMYB103L-overexpression plant, and targeted genes of OsMYB103L by DAP-seq. C The most significant terms of overlapped genes by GO analysis. D Co-expression analysis of 11 overlapped genes in two different stem tissues. Stem 1, stem at 5 days before heading. Stem 2, stem at heading stage
Candidate genes regulated by OsMYB103L for cellulose synthesis and assembly
| Biological processes | Genes | Putative function | log2(fold_change) in | log2(fold_change) in |
|---|---|---|---|---|
| Cellulose synthesis | CESA4—cellulose synthase, expressed | − 1.62 down | 3.59 up | |
| CESA7—cellulose synthase, expressed | − 2.01 down | 1.70 up | ||
| CSLA11—cellulose synthase-like family A, expressed | − 2.55 down | − 4.25 down | ||
| Cellulose deposition | BC1, COBRA-like protein precursor, putative, expressed | − 2.49 down | 2.39 up | |
| Kinesin motor domain-containing protein, putative, expressed | − 1.67 down | 1.54 up | ||
| Kinesin motor domain-containing protein, putative, expressed | − 1.56 down | − 2.74 down | ||
| Kinesin motor domain-containing protein, expressed | − 1.30 down | − 2.64 down | ||
| Kinesin motor domain-containing protein, putative, expressed | − 1.05 down | 1.46 up | ||
| Tubulin/FtsZ domain-containing protein, putative, expressed | − 1.42 down | 3.36 up | ||
| Microtubule-associated protein, putative, expressed | − 1.34 down | 2.38 up | ||
| Dynamin family protein, putative, expressed | − 1.18 down | 1.44 up |